ARTICLE | Clinical News
CD34+ stem cell therapy: Phase IIa data
November 22, 2010 8:00 AM UTC
Researchers at Northwestern University's Feinberg School of Medicine reported data from a double-blind, U.S. Phase IIa trial in 28 patients with late-stage peripheral arterial disease (PAD) and CLI sh...